Volume 51, Issue 1, Pages 161-167 (January 2007)
Abstract -
Objectives:
Although Bacillus Calmette-Guérin (BCG) instillations are considered as the adjuvant treatment of choice for stage Ta-T1 grade G3 bladder tumours, there is no consensus for a predictive factor to assess BCG success.
Your session will expire in 8 hours requiring you to log in each day to view content.
Browse Categories
European Urology - HSP90 Expression: A New Predictive Factor for BCG Response in Stage Ta-T1 Grade 3 Bladder Tumours
